Home/Filings/4/0001641489-24-000078
4//SEC Filing

SEKHRI PAUL J 4

Accession 0001641489-24-000078

CIK 0001641489other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 4:31 PM ET

Size

9.3 KB

Accession

0001641489-24-000078

Insider Transaction Report

Form 4
Period: 2024-11-15
SEKHRI PAUL J
DirectorPres, CEO and Exec Chairperson
Transactions
  • Purchase

    Class A Common Stock

    2024-11-15$16.88/sh+1,778$30,0093,156 total
  • Purchase

    Class A Common Stock

    2024-11-15$16.35/sh+1,378$22,5341,378 total
  • Purchase

    Class A Common Stock

    2024-11-18$16.96/sh+1,844$31,2695,000 total
Footnotes (4)
  • [F1]The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Sekhri on August 13, 2024.
  • [F2]The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $15.65 to $16.50. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $16.71 to $17.00. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $16.70 to $17.00. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

vTv Therapeutics Inc.

CIK 0001641489

Entity typeother

Related Parties

1
  • filerCIK 0001264519

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:31 PM ET
Size
9.3 KB